Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
IIB
118TH CONGRESS
2D SESSION
H. R. 3884
IN THE SENATE OF THE UNITED STATES
SEPTEMBER 24, 2024
Received; read twice and referred to the Committee on Health, Education,
Labor, and Pensions
AN ACT
To amend title XI of the Public Health Service Act to
reauthorize the program providing for sickle cell disease
and other heritable blood disorders research, surveillance,
prevention, and treatment.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
VerDate Sep 11 2014
03:02 Sep 25, 2024
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H3884.RFS
H3884
ssavage on LAPJG3WLY3PROD with BILLS
2
HR 3884 RFS
SECTION 1. SHORT TITLE.
1
This Act may be cited as the ‘‘Sickle Cell Disease
2
and Other Heritable Blood Disorders Research, Surveil-
3
lance, Prevention, and Treatment Act of 2023’’.
4
SEC. 2. REAUTHORIZATION OF SICKLE CELL DISEASE AND
5
OTHER HERITABLE BLOOD DISORDERS RE-
6
SEARCH, SURVEILLANCE, PREVENTION, AND
7
TREATMENT.
8
Section 1106(b) of the Public Health Service Act (42
9
U.S.C. 300b–5(b)) is amended—
10
(1) in paragraph (3)(A), by inserting ‘‘, grant,
11
or cooperative agreement’’ after ‘‘contract’’; and
12
(2) in paragraph (6), by striking ‘‘$4,455,000
13
for each of fiscal years 2019 through 2023’’ and in-
14
serting ‘‘$8,205,000 for each of fiscal years 2024
15
through 2028’’.
16
Passed the House of Representatives September 23,
2024.
Attest:
KEVIN F. MCCUMBER,
Clerk.
VerDate Sep 11 2014
03:02 Sep 25, 2024
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H3884.RFS
H3884
ssavage on LAPJG3WLY3PROD with BILLS